Baxter International Inc.

BAX Healthcare Medical Instruments & Supplies

Baxter International Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.2 billion, up 5.72% from fiscal 2024. In the quarter to June 2026, revenue grew 5.34%, EPS grew 33.3%, free cash flow grew 119.5% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years.

25.33 0.43 −1.67%
Market cap
$13.3B
P/E
0.0×
Fwd P/E
44.7×
Dividend yield
0.16%
F-score
4/9
Altman Z
2.12
Beneish M
−2.67
Dividend safety
0/100

Baxter International Inc. (BAX) Total debt

Alert me on Total debt

Baxter International Inc.'s total debt at the end of fiscal 2025 was $9.5B, down 27.8% from $13.1B in fiscal 2024. At the end of the quarter to 30 June 2026 it was $9.5B. Over the past ten years it has ranged from $2.8B (fiscal 2016) to $17.7B (fiscal 2021); the current reading is higher than 64% of that period. Baxter International Inc. ranks 3rd of 54 Medical Instruments & Supplies companies by total debt.

Total debt, annual

Embed this chart

Annual newest first

Period Total debt Change
FY2025 $9.5B (27.81%)
FY2024 $13.1B (4.58%)
FY2023 $13.8B (17.31%)
FY2022 $16.6B (5.80%)
FY2021 $17.7B 185.21%
FY2020 $6.2B 15.74%
FY2019 $5.4B 53.52%
FY2018 $3.5B (0.77%)
FY2017 $3.5B 26.24%
FY2016 $2.8B (57.25%)

Quarterly newest first

Period Total debt Change
Jun 2026 $9.5B (0.04%)
Mar 2026 $9.5B (0.14%)
Dec 2025 $9.5B (0.27%)
Sep 2025 $9.5B 0.02%
42 more quarters

Against its own ten years

Low $2.8B High $17.7B
Ten-year median $6.5B
Current reading's percentile 64

Total debt against peers

What Total debt is

Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.

Long Term Debt (Total) + Current Part of Debt

The full definition of Total debt →

More on BAX